News & Updates
Filter by Specialty:
TAF useful in pregnant women with chronic hepatitis B infection
Treatment with tenofovir alafenamide (TAF) for pregnant women with active chronic hepatitis B (CHB) infection, when administered throughout or initiated early in pregnancy, is effective and safe in both mothers and infants, according to a study.
TAF useful in pregnant women with chronic hepatitis B infection
20 Dec 2021
Foetal brain unaffected by mild-to-moderate COVID-19 in pregnancy
Mild-to-moderate COVID-19 during pregnancy does not appear to affect the foetal brain, according to a prospective study presented at RSNA 2021.
Foetal brain unaffected by mild-to-moderate COVID-19 in pregnancy
20 Dec 2021
Extracorporeal CO2 removal safe, effective for acute exacerbation of COPD
Extracorporeal CO2 removal (ECCO2R) devices significantly improve pH and carbon dioxide arterial pressure (PaCO2) in patients with acute exacerbation of chronic obstructive pulmonary disease (ae-COPD) who had previously failed noninvasive ventilation (NIV), according to a recent study.
Extracorporeal CO2 removal safe, effective for acute exacerbation of COPD
20 Dec 2021
COVID-19 causes lighter heart damage during second vs first wave of infections
In fatal cases of the coronavirus disease 2019 (COVID-19), cardiac inflammation, cardiomyocyte injury, and microvascular thrombogenicity are substantially lower in the second vs first wave of infections, a new study has found.
